Analysts from CGS-CIMB, RHB Group Research and PhillipCapital have maintained their “buy” and “add” ratings on Manulife US REIT (MUST), despite a dip to the Trust’s portfolio occupancy. 

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply